A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Alcohol
This training is designed to provide an introductory overview of alcohol use disorders. We will explore the latest epidemiological data, with a focus on the prevalence and trends of alcohol use and alcohol use disorders in the United States. Diagnostic criteria and screening tools to assess for alcohol use disorders will be discussed. Additionally, we will examine evidence-based interventions to treat alcohol use disorders and support individuals in their recovery.
![]() |
Tuesday, 7/8/2025 9:00 am – 10:00 am ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Stimulants
This training provides an introduction to stimulant use disorder, including evidence-informed treatments and interventions.
![]() |
Thursday, 7/17/2025 12:00 pm – 1:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training is designed to provide foundational knowledge and skills in initiating buprenorphine treatment for opioid use disorder in the outpatient setting in the context of the widespread presence of illicitly manufactured fentanyl. We explore how the potency and prevalence of fentanyl complicates the initiation phase of buprenorphine treatment, leading to potential clinical challenges such as precipitated withdrawal. We suggest participating in the next training in the series, Buprenorphine 201, upon completing Buprenorphine 101.
![]() |
Friday, 7/25/2025 12:00 pm – 1:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |